383 related articles for article (PubMed ID: 24456244)
1. Late-onset Pneumocystis jirovecii pneumonia in solid organ transplant recipients.
Perez-Ordoño L; Hoyo I; Sanclemente G; Ricart MJ; Cofan F; Perez-Villa F; de la Bellacasa JP; Moreno A; Cervera C
Transpl Infect Dis; 2014 Apr; 16(2):324-8. PubMed ID: 24456244
[TBL] [Abstract][Full Text] [Related]
2. Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past.
Wang EH; Partovi N; Levy RD; Shapiro RJ; Yoshida EM; Greanya ED
Transpl Infect Dis; 2012 Oct; 14(5):519-25. PubMed ID: 22571389
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C;
Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of once-weekly dapsone dosing for Pneumocystis jirovecii pneumonia prophylaxis post transplantation.
Evans RA; Clifford TM; Tang S; Au T; Fugit AM
Transpl Infect Dis; 2015 Dec; 17(6):816-21. PubMed ID: 26369753
[TBL] [Abstract][Full Text] [Related]
5. Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation.
Werbel WA; Ison MG; Angarone MP; Yang A; Stosor V
Transpl Infect Dis; 2018 Jun; 20(3):e12876. PubMed ID: 29512868
[TBL] [Abstract][Full Text] [Related]
6. Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following renal transplantation.
Gabardi S; Millen P; Hurwitz S; Martin S; Roberts K; Chandraker A
Clin Transplant; 2012; 26(3):E184-90. PubMed ID: 22487221
[TBL] [Abstract][Full Text] [Related]
7. Pneumocystis jirovecii pneumonia in renal transplant recipients: a national center experience.
Borstnar S; Lindic J; Tomazic J; Kandus A; Pikelj A; Prah J; Skvarc M; Godnov U; Kovac D
Transplant Proc; 2013 May; 45(4):1614-7. PubMed ID: 23726632
[TBL] [Abstract][Full Text] [Related]
8. Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention.
Saadatzadeh T; Angarone M; Stosor V
Curr Opin Infect Dis; 2024 Apr; 37(2):121-128. PubMed ID: 38230604
[TBL] [Abstract][Full Text] [Related]
9. [Pneumocystis pneumonia in a renal transplant recipient].
Özkoç S; İnceboz T; Sıfıl A; Tuncay S; Akisü Ç
Turkiye Parazitol Derg; 2010; 34(4):186-9. PubMed ID: 21391190
[TBL] [Abstract][Full Text] [Related]
10. Current Concepts in the Diagnosis and Management of Pneumocystis Pneumonia in Solid Organ Transplantation.
Trubin PA; Azar MM
Infect Dis Clin North Am; 2023 Sep; 37(3):617-640. PubMed ID: 37142510
[TBL] [Abstract][Full Text] [Related]
11. Pneumocystis jirovecii pneumonia in kidney transplantation.
Goto N; Oka S
Transpl Infect Dis; 2011 Dec; 13(6):551-8. PubMed ID: 22093172
[TBL] [Abstract][Full Text] [Related]
12. Pneumocystis jirovecii pneumonia is rare in renal transplant recipients receiving only one month of prophylaxis.
Anand S; Samaniego M; Kaul DR
Transpl Infect Dis; 2011 Dec; 13(6):570-4. PubMed ID: 22093215
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of Pneumocystis jirovecii pneumonia in HIV-infected or non-HIV-infected patients-difficulties in diagnosis and adverse effects of trimethoprim-sulfamethoxazole.
Kato H; Samukawa S; Takahashi H; Nakajima H
J Infect Chemother; 2019 Nov; 25(11):920-924. PubMed ID: 31300379
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.
Park SY; Jung JH; Kwon H; Shin S; Kim YH; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH; Han DJ
Transpl Infect Dis; 2020 Apr; 22(2):e13245. PubMed ID: 31943590
[TBL] [Abstract][Full Text] [Related]
15. Predisposing factors, clinical characteristics and outcome of Pneumonocystis jirovecii pneumonia in HIV-negative patients.
Kofteridis DP; Valachis A; Velegraki M; Antoniou M; Christofaki M; Vrentzos GE; Andrianaki AM; Samonis G
J Infect Chemother; 2014 Jul; 20(7):412-6. PubMed ID: 24767467
[TBL] [Abstract][Full Text] [Related]
16. A heart transplant recipient lost due to Pneumocystis jiroveci pneumonia under trimethoprim-sulfamethoxazole prophylaxis: case report.
Celik T; Gedik E; Kayabas U; Bayindir Y; Gulbas G; Firat AK; Togal T
Exp Clin Transplant; 2010 Dec; 8(4):325-8. PubMed ID: 21143101
[TBL] [Abstract][Full Text] [Related]
17. No recurrence of Pneumocystis jirovecii Pneumonia after solid organ transplantation regardless of secondary prophylaxis.
Kim T; Sung H; Lee YM; Hong HL; Kim SH; Choi SH; Woo JH; Kim YS; Lee SO
Antimicrob Agents Chemother; 2012 Nov; 56(11):6041-3. PubMed ID: 22948875
[TBL] [Abstract][Full Text] [Related]
18. An outbreak of Pneumocytis jirovecii pneumonia among liver transplant recipients.
Miguel Montanes R; Elkrief L; Hajage D; Houssel P; Fantin B; Francoz C; Dreyfuss D; Ricard JD; Durand F
Transpl Infect Dis; 2018 Oct; 20(5):e12956. PubMed ID: 29896781
[TBL] [Abstract][Full Text] [Related]
19. Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin's lymphoma.
Venhuizen AC; Hustinx WN; van Houte AJ; Veth G; van der Griend R
Eur J Haematol; 2008 Mar; 80(3):275-6. PubMed ID: 18005387
[No Abstract] [Full Text] [Related]
20. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
Zmarlicka M; Martin ST; Cardwell SM; Nailor MD
Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
